Guidelines - Cancer & Palliative Care. Nov/Dec 2017

From Guidelines bulletin, November/December 2017.
Link to full bulletin: http://www.knowledge.scot.nhs.uk/cabs/topics/guidelines.aspx

1. UK

NICE, 2017. Atezolizumab for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable. TA492. NICE, Dec 2017. https://www.nice.org.uk/guidance/ta492 [11.12.17]

NICE, 2017. HTG EdgeSeq ALKPlus Assay EU for ALK status testing in non-small-cell lung cancer.MIB128.  NICE, Nov 2017. https://www.nice.org.uk/advice/mib128 [1.12.17]

NICE, 2017. Ibrutinib for treating Waldenstrom’s macroglobulinaemia. TA491. NICE, Nov 2017. https://www.nice.org.uk/guidance/ta491 [1.12.17]

NICE, 2017. Nivolumab for previously treated advanced renal cell carcinoma. TA417. NICE, Nov 2016, updated Nov 2017. https://www.nice.org.uk/guidance/ta417 [1.12.17]

NICE, 2017. Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma. TA462. NICE, July 2017, updated Nov 2017. https://www.nice.org.uk/guidance/ta462 [1.12.17]

NICE, 2017. Nivolumab for treating squamous cell carcinoma of the head and neck after platinum-based chemotherapy. TA490. NICE, Nov 2017. https://www.nice.org.uk/guidance/ta490 [1.12.17]

NICE, 2017. Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours. TA488. NICE, Nov 2017. https://www.nice.org.uk/guidance/ta488 [1.12.17]

NICE, 2017. Suspected cancer. QS124. NICE, June 2016, updated Dec 2017. https://www.nice.org.uk/guidance/qs124 [11.12.17]

NICE, 2017. Tests in secondary care to identify people at high risk of ovarian cancer. DG31. NICE, Nov 2017. https://www.nice.org.uk/guidance/dg31 [1.12.17]

NICE, 2017. Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxane. TA458. NICE, July 2017, updated Nov 2017. https://www.nice.org.uk/guidance/ta458 [1.12.2017]

NICE, 2017. Venetoclax for treating chronic lymphocytic leukaemia. TA487. NICE, Nov 2017. https://www.nice.org.uk/guidance/ta487 [1.12.17]

NICE, 2017. Vismodegib for treating basal cell carcinoma. TA489. NICE, Nov 2017. https://www.nice.org.uk/guidance/ta489 [1.12.17]

2. International

ARBER, D.A., et al, 2017. Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology. Archives of Pathology & Laboratory Medicine, 141(10), pp. 1342-1393.
Check for full text.  Athens login required.

BALIS, F.M., et al, 2017. Dosing anticancer drugs in infants: Current approach and recommendations from the Children's Oncology Group's Chemotherapy Standardization Task Force. Pediatric Blood & Cancer, 64(11),
Check for full text.  Athens login required.

BARANISKIN, A., et al, 2017. Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona. European journal of cancer, 86, pp. 305-317. Check for full text.  Athens login required.

GILLIGAN, T., et al, 2017. Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline. Journal of Clinical Oncology, 35(31), pp. 3618-3632.
Check for full text.  Athens login required.

HANNA, N., et al, 2017. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology, 35(30), pp. 3484-3515. Check for full text.  Athens login required.

KROP, I., et al, 2017. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Focused Update Guideline Summary. Journal of Oncology Practice, 13(11), pp. 763-766. Check for full text.  Athens login required.

LOBLAW, A., et al, 2017. Follow-up Care for Survivors of Prostate Cancer – Clinical Management: a Program in Evidence-Based Care Systematic Review and Clinical Practice Guideline. Clinical Oncology, 29(11), pp. 711-717. Check for full text.  Athens login required.

MAR, V.J., et al, 2017. Clinical practice guidelines for the diagnosis and management of melanoma: melanomas that lack classical clinical features. Medical Journal of Australia, 207(8), pp. 348-350. Check for full text.  Athens login required.

OLVER, I., et al, 2017. 2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential. Supportive Care in Cancer, 25(1), pp. 297-301. Check for full text.  Athens login required.

PATEL, P., et al, 2017. Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cance r patients: A focused update. Pediatric Blood & Cancer, 64(10). Check for full text.  Athens login required.

SUN, A., et al., 2017. Initial management of small cell lung cancer (limited and extensive stage) and the role of thoracic radiotherapy and first-line chemotherapy. Cancer Care Ontario, Oct 2017. https://www.cancercareontario.ca/en/guidelines-advice/types-of-cancer/49411 [11.12.17]

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. 2017. Journal of Clinical Oncology, 35(30), pp. 1-42. Check for full text.  Athens login required.

VAN DAM, P., et al, 2017. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis. British journal of cancer, 117(10), pp. 1427-1441. Check for full text.  Athens login required.